The review concluded that there was no definitive evidence that laser epithelial keratomileusis (LASEK) was better than photorefractive keratectomy (PRK) for correcting myopia from 0 to -9.0 dioptres. The review had some methodological weaknesses, but the authors' conclusion is likely to be reliable given the evidence available.
To compare the efficacy, accuracy, safety and side-effects of laser epithelial keratomileusis (LASEK) and photorefractive keratectomy (PRK) for the correction of myopia.
Searching
PubMed, EMBASE, Chinese Bio-medicine Database and Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception to November 2007 for publications in English and Chinese. Search terms were reported.
Study selection
Randomised controlled trials (RCTs) that compared LASEK with PRK in patients aged 18 to 60 years with any degree of myopia and astigmatism of up to three dioptres were eligible for inclusion. Outcomes of interest included efficacy outcomes (proportion of eyes with uncorrected visual acuity (UCVA) ≥20/20 at one month and 12 months posttreatment), accuracy outcomes (proportion of eyes within ±0.50 dioptres of target refraction at one month and 12 months post-treatment), safety outcomes (loss of ≥2 lines of best spectacle-corrected visual acuity (BSCVA) at six months or more post-treatment), pain scores on day one post-treatment and corneal haze scores at six and 12 months post-treatment.
Mean preoperative spherical equivalent refraction was -3.39 for LASEK and -4.37 for PRK. Mean age of patients was 27.8 years. Outcomes reported included efficacy, accuracy and safety outcomes and mean pain and mean corneal haze scores. The laser systems used were varied.
The authors stated neither how the papers were selected for review nor how many reviewers performed the selection.
Assessment of study quality
Study quality was assessed by adequacy of allocation concealment, randomisation, masking, intention-to-treat-analysis and descriptions of withdrawals or dropouts.
Two reviewers independently assessed study quality using a standardised form and resolved any disagreements by discussion.
Data extraction
Data on efficacy, accuracy and safety measures and on the degree of reported side-effects were extracted in order to calculate odds ratios (ORs) and corresponding 95% confidence intervals (CIs).
Two reviewers independently extracted data and any disagreements were resolved by discussion. Authors were contacted for missing data.
Methods of synthesis
Mean pain and corneal haze scores were combined by calculating weighted mean differences (WMDs) and corresponding 95% CIs. Pooled odds ratios and corresponding 95% CIs were calculated for dichotomous outcomes
